Cystic Fibrosis: Current Trends in Respiratory Care

The full text article is not available for purchase.

The publisher only permits individual articles to be downloaded by subscribers.

Abstract:

Cystic fibrosis is a genetic disease that typically produces malnutrition and chronic respiratory infections. Prolonged bronchial obstruction, infection, and inflammation result in bronchiectstasis and permanent lung damage. Most cystic fibrosis patients die because of this progressive respiratory disease. Thus, in the absence of a cure, effective respiratory therapy is the primary means to extend and improve the quality of life for the cystic fibrosis patient. Aerosol therapy, airway clearance techniques, and noninvasive ventilation can all improve quality of life and possibly extend survival. Close patient monitoring with pulmonary function testing, chest radiography, and induced sputum can result in earlier treatment, potentially reducing permanent lung damage. Earlier diagnosis has prevented serious complications through early initiation of preventive therapies such as improved nutrition.

Keywords: AIRWAY CLEARANCE; CYSTIC FIBROSIS; PEDIATRIC; PULMONARY; RESPIRATORY; RESPIRATORY CARE

Document Type: Research Article

Affiliations: 1: Department of Pediatrics, University of Colorado School of Medicine, and The Children's Hospital B-395, 1056 E 19th Avenue, Denver Colorado 80218 2: Department of Pediatrics, University of Colorado School of Medicine, and The Children's Hospital, Denver, Colorado

Publication date: March 1, 2003

More about this publication?
Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more